Study details
Enrolling now
Study to Evaluate Budesonide for Ulcerative Colitis in Children
Bausch Health Americas, Inc.
NCT IDNCT04314375ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
70
Study length
about 3.8 years
Ages
5–17
Locations
4 sites in CA, IN, NC +1
What this study is about
Researchers are testing a treatment called budesonide, which is a type of medication, to see if it helps children with mild to moderate ulcerative colitis. The trial will last 1370 days and involve about 70 children who have active ulcerative colitis.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take High Dose Budesonide
- 2.Take Low Dose Budesonide
- 3.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
ALIMENTARY TRACT AND METABOLISM
Drug routes
oral (Delayed Release Oral Capsule)
Body systems
Gastroenterology